Jaccoud arthropathy affecting multiple joint sites simultaneously — a chronic, deforming arthropathy that develops as a sequela of repeated rheumatic inflammation, characterized by reducible joint deformities without significant cartilage destruction.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 6
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M12.09.
Source · Editorial brief grounded in 5 cited references ↓
- Explicitly name each joint site affected by Jaccoud arthropathy — 'bilateral MCP joints and right ankle' is billable specificity; 'multiple joints' alone is not sufficient for auditors.
- Document the underlying rheumatic trigger (e.g., prior rheumatic fever, SLE) in the history to support medical necessity and distinguish Jaccoud arthropathy from RA or osteoarthritis.
- Record whether deformities are reducible vs. fixed — reducibility is a defining clinical feature of Jaccoud arthropathy and differentiates it from erosive arthritis that would map elsewhere.
- Note any imaging findings (X-ray, MRI) confirming absence of bony erosion or cartilage loss, which supports the Jaccoud diagnosis and defends against a challenge to code specificity.
- If the patient has an active SLE diagnosis, code that condition as well and sequence appropriately — Jaccoud arthropathy in SLE is a manifestation, not the primary disease.
Related CPT procedures
Procedure codes commonly billed with M12.09. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M12.09 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Defaulting to M12.09 when only one joint is symptomatic at the encounter — use a site-specific code (M12.01–M12.08) when a single region is the focus, reserving M12.09 for genuinely polyarticular presentations.
- Confusing Jaccoud arthropathy with rheumatoid arthritis — M12.09 is not a substitute for M05/M06 codes; the absence of synovial erosion and the post-rheumatic history must be documented to justify this code.
- Applying M12.09 when arthrosis (degenerative joint disease) is the actual diagnosis — the Excludes1 note at M12 bars use of any M12.0x code for conditions classified to M15–M19.
- Failing to code the underlying condition (e.g., SLE with M32.xx) alongside M12.09 when a causal systemic disease is active and documented.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M12.09 applies when a patient has confirmed Jaccoud arthropathy (chronic postrheumatic arthropathy) involving two or more distinct joint sites — for example, bilateral hands plus both ankles, or shoulders and knees together. Jaccoud arthropathy classically follows recurrent rheumatic fever or systemic lupus erythematosus, producing ligamentous laxity and reducible ulnar deviation or swan-neck deformities without the bony erosion typical of RA. The key word in M12.09 is 'multiple sites' — the provider must document more than one affected joint region. If only one region is involved, select the site-specific code from M12.01–M12.08 instead.
Within the M12.0x family, 'multiple sites' (M12.09) is the terminal code when polyarticular involvement is documented and no single joint is the exclusive focus of the encounter. If the encounter is driving treatment at one joint despite polyarticular disease, consider whether a site-specific code better captures the encounter's clinical purpose. M12.09 should not be defaulted to simply because multiple joints are mentioned in the history; the current encounter documentation must reflect active, ongoing Jaccoud arthropathy across those sites.
Note the Excludes1 at the M12 category level: arthrosis (M15–M19) and cricoarytenoid arthropathy (J38.7) are excluded. Do not use M12.09 for degenerative joint disease — the pathology here is ligamentous, post-inflammatory, and distinct from osteoarthritis. Additionally, this code does not carry 7th-character extensions; it is reported as-is.
Sibling codes
Other billable codes under M12.0 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01When does Jaccoud arthropathy qualify as 'multiple sites' for M12.09?
02Can M12.09 be used for a patient with SLE who has joint deformities?
03What is the difference between M12.09 and M12.00?
04Is M12.09 excluded from use with osteoarthritis codes?
05Does M12.09 require a 7th character?
06How do I distinguish Jaccoud arthropathy from rheumatoid arthritis for coding purposes?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
Mira AI Scribe
Mira AI Scribe captures the number and names of affected joint sites, the patient's prior rheumatic disease history, current deformity characteristics (reducible vs. fixed), and any imaging confirming absence of erosive changes. This documentation prevents downcoding to M12.00 (unspecified site) or an audit challenge from payers questioning medical necessity when the encounter involves multiple joint complaints.
See how Mira captures M12.09 documentation